OPKO HEALTH, INC.

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

OPK$1.71-1.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,
	2025	2024
ASSETS
Current assets:
Cash, cash equivalents and current restricted cash	$369,074	$431,936
Accounts receivable, net	90,255	118,017
Inventory, net	65,823	56,797
Other current assets and prepaid expenses	56,729	55,339
Total current assets	581,881	662,089
Property, plant and equipment, net	73,926	70,134
Intangible assets, net	516,276	616,613
In-process research and development	195,000	195,000
Goodwill	484,289	529,252
Investments	14,168	54,584
Operating lease right-of-use assets	46,930	54,003
Other assets	19,474	18,537
Total assets	$1,931,944	$2,200,212
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$41,103	$47,071
Accrued expenses	84,406	118,357
Current maturities of operating leases	10,917	12,649
Current portion of convertible notes	—	170
Current portion of lines of credit and notes payable	10,251	14,849
Total current liabilities	146,677	193,096
Operating lease liabilities	36,815	48,849
Long term portion of convertible notes	85,020	173,606
Senior secured notes	246,433	245,576
Deferred tax liabilities	126,241	140,799
Other long-term liabilities, principally contingent consideration and lines of credit	22,799	32,838
Total long-term liabilities	517,308	641,668
Total liabilities	663,985	834,764
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 789,917,433 and 701,350,447 shares issued at December 31, 2025 and 2024, respectively	7,900	7,015
Treasury Stock - 30,849,907, and 29,799,907 shares at December 31, 2025 and December 31, 2024, respectively	(3,176)	(1,791)
Additional paid-in capital	3,574,942	3,481,364
Accumulated other comprehensive loss	(21,017)	(56,130)
Accumulated deficit	(2,290,690)	(2,065,010)
Total shareholders’ equity	1,267,959	1,365,448
Total liabilities and equity	$1,931,944	$2,200,212

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.